SOLID BIOSCIENCES INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.635 USD | -2.84% |
|
-9.21% | -6.84% |
| 24/06 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
| 21/06 | Top Premarket Gainers | MT |
Chart calendar Solid Biosciences Inc.
e3c01ec6a00c0d148a413d91553df.3ISGe_pLGj1lSKxyRdZKc44rYN1k57Pl3Rj4Bz2aSs8.5e7HAqUfbVckJ-IqLI4sKuMSKooKiOWf732rQ2_bLay1yew4sAR3Zy0e3w~ed34eeda65fc4d6244cc580754cdbd1a
Upcoming events on Solid Biosciences Inc.
Past events on Solid Biosciences Inc.
| 11/06/2024 05:30 pm | Annual General Meeting |
| 10/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : 1517 |
| 10/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : 1543 |
| 10/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : 1541 |
| 10/05/2024 03:00 am | American Society of Gene & Cell Therapy Meeting - Abstract No : 1391 |
| 08/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : 480 |
| 08/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : 466 |
| 07/05/2024 11:45 pm | American Society of Gene & Cell Therapy Meeting - Abstract No : #28 |
| 10/04/2024 | Cell & Gene Meeting on the Med Conference |
| 02/04/2024 05:45 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 13/03/2024 11:05 pm | Barclays Global Healthcare Conference |
| 13/03/2024 05:14 pm | Q4 2023 Earnings Release |
| 11/03/2024 | Leerink Partners Global Biopharma Conference |
| 11/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 30/11/2023 11:30 pm | Piper Sandler Healthcare Conference |
| 15/11/2023 10:30 pm | Jefferies London Healthcare Conference |
| 09/11/2023 02:47 am | Q3 2023 Earnings Release |
| 03/10/2023 08:30 pm | Chardan Genetic Medicines Conference |
| 28/09/2023 07:50 pm | Cantor Global Healthcare Conference |
| 27/09/2023 07:30 pm | Jefferies Cell & Genetic Medicine Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 13,6 12,6 8.39% | 8,09 8,10 -0.02% | 0,00 0,88 - | 2,71 |
|
EBITDA Million USD | Released Forecast Spread | -116 -113 -3.17% | -84,5 -87,1 2.99% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -99,3 |
|
EBIT Million USD | Released Forecast Spread | -119 -117 -2.37% | -88,4 -89,2 0.88% | -72,3 -74,7 3.32% | -99,3 -92,3 -7.6% | -104 -108 3.14% | -111 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -117 -114 -2.52% | -88,3 -87,5 -0.96% | -72,2 -74,7 3.31% | -86,0 -90,7 5.15% | -96,0 -99,0 3% | -102 |
|
Net income Million USD | Released Forecast Spread | -117 -114 -2.69% | -88,3 -87,8 -0.56% | -72,2 -76,1 5.17% | -86,0 -91,0 5.5% | -96,0 -98,0 2.07% | -100 |
|
EPS USD | Released Forecast Spread | -43,6 -42,3 -3.28% | -25,5 -24,3 -4.96% | -10,2 -10,7 5.12% | -10,1 -5,03 -100.85% | -4,83 -4,69 -2.9% | -2,67 |
| Announcement Date | 12/03/20 | 15/03/21 | 14/03/22 | 23/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,93 2,68 -28.12% | 6,20 2,73 127.21% | 0,00 1,57 - | 0,00 0,00 - | 0,00 1,47 - | 0,00 1,47 - | 0,00 1,10 - | 0,00 0,88 - | 0,00 1,04 - | 0,90 | 0,90 | 0,90 | 0,45 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -25,3 -18,7 -35.07% | -24,0 | -24,3 | -24,5 | -25,1 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -25,4 -20,8 -21.85% | -25,4 -24,5 -3.6% | -21,1 -21,9 3.51% | -28,9 -20,6 -40.33% | -32,0 -26,3 -21.67% | -26,8 -32,5 17.41% | -23,1 -27,2 14.94% | -22,3 -25,8 13.59% | -26,9 -22,9 -17.19% | -27,1 | -28,1 | -29,0 | -28,4 | -31,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,3 -20,8 -21.69% | -25,1 -24,5 -2.51% | -20,4 -21,7 5.94% | -15,2 -19,7 23.24% | -30,1 -24,6 -22.36% | -24,6 -31,0 20.6% | -21,0 -25,2 16.77% | -20,3 -23,4 13.18% | -24,3 -21,2 -14.46% | -24,8 | -25,7 | -26,8 | -25,3 | -28,6 |
|
Net income Million USD | Released Forecast Spread | -25,3 -20,5 -23.64% | -25,1 -24,9 -1% | -20,4 -23,7 13.7% | -15,2 -20,2 24.97% | -30,1 -24,7 -21.99% | -24,6 -29,9 17.76% | -21,0 -24,1 12.89% | -20,3 -22,5 9.49% | -24,3 -20,9 -16.22% | -24,4 | -25,1 | -26,1 | -25,3 | -28,6 |
|
EPS USD | Released Forecast Spread | -3,30 -2,70 -22.09% | -3,30 -3,29 -0.2% | -2,71 -2,31 -17.22% | -0,68 -2,07 67.09% | -1,54 -2,05 24.97% | -1,25 -1,54 18.58% | -1,05 -1,19 11.56% | -1,00 -0,96 -4.46% | -0,64 -0,58 -11.13% | -0,64 | -0,65 | -0,66 | -0,69 | -0,72 |
| Announcement Date | 27/04/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 14/08/23 | 08/11/23 | 13/03/24 | 15/05/24 | - | - | - | - | - |
More events
Past sector events for Solid Biosciences Inc.
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLDB Stock
- Calendar Solid Biosciences Inc.
